Davita Healthcare Partners Inc
(DVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,021,294 | 333,040 | 830,555 | 1,033,082 | 427,410 |
| Depreciation Amortization | 615,152 | 591,035 | 777,485 | 720,252 | 638,024 |
| Income taxes - deferred | 41,723 | 273,660 | -395,217 | 52,010 | 61,744 |
| Accounts receivable | -79,957 | -81,176 | -156,305 | -152,240 | -202,867 |
| Accounts payable and accrued liabilities | -84,539 | -35,959 | 26,876 | 11,897 | 30,998 |
| Other Working Capital | 86,859 | 98,899 | -388,781 | 225,778 | 59,843 |
| Other Operating Activity | 471,823 | 592,141 | 1,218,553 | 81,347 | 542,048 |
| Operating Cash Flow | $2,072,355 | $1,771,640 | $1,913,166 | $1,972,126 | $1,557,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 93,594 | 29,977 | 256,771 | 112,734 | -79,250 |
| PPE Investments | 3,110,846 | -836,933 | -812,914 | -764,370 | -688,283 |
| Net Acquisitions | -100,861 | -183,156 | -803,879 | -563,856 | -96,469 |
| Purchase Of Investment | -110,828 | -19,177 | -4,816 | -27,096 | -17,911 |
| Sale Of Investment | N/A | N/A | N/A | 40,920 | N/A |
| Other Investing Activity | 2,589 | 3,646 | 106 | 0 | 129 |
| Investing Cash Flow | $2,995,340 | $-1,005,643 | $-1,364,732 | $-1,201,668 | $-881,784 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 38,525,850 | 59,934,750 | 50,991,960 | 51,991,490 | 54,541,990 |
| Debt Repayment | -40,520,720 | -59,234,950 | -50,837,110 | -52,116,120 | -53,998,960 |
| Common Stock Issued | 11,382 | 13,577 | 21,252 | 23,543 | 26,155 |
| Common Stock Repurchased | -2,383,816 | -1,161,511 | -802,949 | -1,097,822 | -549,935 |
| Other Financing Activity | -329,146 | -177,220 | -139,410 | -153,072 | -158,220 |
| Financing Cash Flow | $-4,696,450 | $-625,354 | $-766,257 | $-1,351,981 | $-138,970 |
| Exchange Rate Effect | -1,760 | -3,350 | 254 | 4,276 | -2,571 |
| Beginning Cash Position | 415,420 | 518,920 | 683,463 | 1,244,917 | 736,897 |
| End Cash Position | 1,208,718 | 415,420 | 518,920 | 683,463 | 1,244,917 |
| Net Cash Flow | $793,298 | $-103,500 | $-164,543 | $-561,454 | $508,020 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,072,355 | 1,771,640 | 1,913,166 | 1,972,126 | 1,557,200 |
| Capital Expenditure | -766,546 | -987,138 | -905,250 | -829,095 | -707,998 |
| Free Cash Flow | 1,305,809 | 784,502 | 1,007,916 | 1,143,031 | 849,202 |